Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical gastroenterology 2006-01, Vol.40 (1), p.88
Hauptverfasser: Sato, Shuichi, Furuta, Kouichiro, Miyake, Tatsuya, Mishiro, Tomoko, Kohge, Naruaki, Akagi, Shuji, Uchida, Yasushi, Rumi, M A K, Ishihara, Shunji, Adachi, Kyouichi, Kinoshita, Yoshikazu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 88
container_title Journal of clinical gastroenterology
container_volume 40
creator Sato, Shuichi
Furuta, Kouichiro
Miyake, Tatsuya
Mishiro, Tomoko
Kohge, Naruaki
Akagi, Shuji
Uchida, Yasushi
Rumi, M A K
Ishihara, Shunji
Adachi, Kyouichi
Kinoshita, Yoshikazu
description
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16340643</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16340643</sourcerecordid><originalsourceid>FETCH-LOGICAL-p543-2d1e008ede66b7bbaafa619fa638218965724973d9926b3ccc59b16797d1b1c03</originalsourceid><addsrcrecordid>eNo1kE1OwzAQhbMA0VK4ApoLRLLj1KmXqAKKhMSm-2psT4ghsSPboep5uCgpP5sZ6c333pPmolgyrqqSNYotiuuU3hnjjRD8qlhwKWoma7EsvnY0hP6UnQH0NDgEO0Xn36Cq4Uj0kSC0EJ3GTzfLM2PB-UyxpRh8if3YYaXBhEE7j9kFD7mjiOMJbKAEPuSZb_uJvKHzCQxG69BAO3nzw8_54-wknxMcXe5gbsIeOjqr2SXY3hSXLfaJbv_2qtg_Puy3u_Ll9el5e_9SjutalJXlxNiGLEmpG60RW5RczUNsKr5Rct1UtWqEVaqSWhhj1kpz2ajGcs0NE6vi7jd2nPRA9jBGN2A8Hf6fJb4Btvxobg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Sato, Shuichi ; Furuta, Kouichiro ; Miyake, Tatsuya ; Mishiro, Tomoko ; Kohge, Naruaki ; Akagi, Shuji ; Uchida, Yasushi ; Rumi, M A K ; Ishihara, Shunji ; Adachi, Kyouichi ; Kinoshita, Yoshikazu</creator><creatorcontrib>Sato, Shuichi ; Furuta, Kouichiro ; Miyake, Tatsuya ; Mishiro, Tomoko ; Kohge, Naruaki ; Akagi, Shuji ; Uchida, Yasushi ; Rumi, M A K ; Ishihara, Shunji ; Adachi, Kyouichi ; Kinoshita, Yoshikazu</creatorcontrib><identifier>ISSN: 0192-0790</identifier><identifier>PMID: 16340643</identifier><language>eng</language><publisher>United States</publisher><subject>Anemia, Hemolytic - chemically induced ; Drug Therapy, Combination ; Female ; Hemoglobins - analysis ; Hemoglobins - drug effects ; Hepatitis C, Chronic - drug therapy ; Humans ; Interferon alpha-2 ; Interferon-alpha - adverse effects ; Interferon-alpha - therapeutic use ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Natriuretic Peptide, Brain - drug effects ; Recombinant Proteins ; Ribavirin - adverse effects ; Ribavirin - therapeutic use</subject><ispartof>Journal of clinical gastroenterology, 2006-01, Vol.40 (1), p.88</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16340643$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Shuichi</creatorcontrib><creatorcontrib>Furuta, Kouichiro</creatorcontrib><creatorcontrib>Miyake, Tatsuya</creatorcontrib><creatorcontrib>Mishiro, Tomoko</creatorcontrib><creatorcontrib>Kohge, Naruaki</creatorcontrib><creatorcontrib>Akagi, Shuji</creatorcontrib><creatorcontrib>Uchida, Yasushi</creatorcontrib><creatorcontrib>Rumi, M A K</creatorcontrib><creatorcontrib>Ishihara, Shunji</creatorcontrib><creatorcontrib>Adachi, Kyouichi</creatorcontrib><creatorcontrib>Kinoshita, Yoshikazu</creatorcontrib><title>Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C</title><title>Journal of clinical gastroenterology</title><addtitle>J Clin Gastroenterol</addtitle><subject>Anemia, Hemolytic - chemically induced</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Hemoglobins - analysis</subject><subject>Hemoglobins - drug effects</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Interferon alpha-2</subject><subject>Interferon-alpha - adverse effects</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Natriuretic Peptide, Brain - drug effects</subject><subject>Recombinant Proteins</subject><subject>Ribavirin - adverse effects</subject><subject>Ribavirin - therapeutic use</subject><issn>0192-0790</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1OwzAQhbMA0VK4ApoLRLLj1KmXqAKKhMSm-2psT4ghsSPboep5uCgpP5sZ6c333pPmolgyrqqSNYotiuuU3hnjjRD8qlhwKWoma7EsvnY0hP6UnQH0NDgEO0Xn36Cq4Uj0kSC0EJ3GTzfLM2PB-UyxpRh8if3YYaXBhEE7j9kFD7mjiOMJbKAEPuSZb_uJvKHzCQxG69BAO3nzw8_54-wknxMcXe5gbsIeOjqr2SXY3hSXLfaJbv_2qtg_Puy3u_Ll9el5e_9SjutalJXlxNiGLEmpG60RW5RczUNsKr5Rct1UtWqEVaqSWhhj1kpz2ajGcs0NE6vi7jd2nPRA9jBGN2A8Hf6fJb4Btvxobg</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>Sato, Shuichi</creator><creator>Furuta, Kouichiro</creator><creator>Miyake, Tatsuya</creator><creator>Mishiro, Tomoko</creator><creator>Kohge, Naruaki</creator><creator>Akagi, Shuji</creator><creator>Uchida, Yasushi</creator><creator>Rumi, M A K</creator><creator>Ishihara, Shunji</creator><creator>Adachi, Kyouichi</creator><creator>Kinoshita, Yoshikazu</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200601</creationdate><title>Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C</title><author>Sato, Shuichi ; Furuta, Kouichiro ; Miyake, Tatsuya ; Mishiro, Tomoko ; Kohge, Naruaki ; Akagi, Shuji ; Uchida, Yasushi ; Rumi, M A K ; Ishihara, Shunji ; Adachi, Kyouichi ; Kinoshita, Yoshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p543-2d1e008ede66b7bbaafa619fa638218965724973d9926b3ccc59b16797d1b1c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Anemia, Hemolytic - chemically induced</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Hemoglobins - analysis</topic><topic>Hemoglobins - drug effects</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Interferon alpha-2</topic><topic>Interferon-alpha - adverse effects</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Natriuretic Peptide, Brain - drug effects</topic><topic>Recombinant Proteins</topic><topic>Ribavirin - adverse effects</topic><topic>Ribavirin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Shuichi</creatorcontrib><creatorcontrib>Furuta, Kouichiro</creatorcontrib><creatorcontrib>Miyake, Tatsuya</creatorcontrib><creatorcontrib>Mishiro, Tomoko</creatorcontrib><creatorcontrib>Kohge, Naruaki</creatorcontrib><creatorcontrib>Akagi, Shuji</creatorcontrib><creatorcontrib>Uchida, Yasushi</creatorcontrib><creatorcontrib>Rumi, M A K</creatorcontrib><creatorcontrib>Ishihara, Shunji</creatorcontrib><creatorcontrib>Adachi, Kyouichi</creatorcontrib><creatorcontrib>Kinoshita, Yoshikazu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of clinical gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Shuichi</au><au>Furuta, Kouichiro</au><au>Miyake, Tatsuya</au><au>Mishiro, Tomoko</au><au>Kohge, Naruaki</au><au>Akagi, Shuji</au><au>Uchida, Yasushi</au><au>Rumi, M A K</au><au>Ishihara, Shunji</au><au>Adachi, Kyouichi</au><au>Kinoshita, Yoshikazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C</atitle><jtitle>Journal of clinical gastroenterology</jtitle><addtitle>J Clin Gastroenterol</addtitle><date>2006-01</date><risdate>2006</risdate><volume>40</volume><issue>1</issue><spage>88</spage><pages>88-</pages><issn>0192-0790</issn><cop>United States</cop><pmid>16340643</pmid></addata></record>
fulltext fulltext
identifier ISSN: 0192-0790
ispartof Journal of clinical gastroenterology, 2006-01, Vol.40 (1), p.88
issn 0192-0790
language eng
recordid cdi_pubmed_primary_16340643
source MEDLINE; Journals@Ovid Complete
subjects Anemia, Hemolytic - chemically induced
Drug Therapy, Combination
Female
Hemoglobins - analysis
Hemoglobins - drug effects
Hepatitis C, Chronic - drug therapy
Humans
Interferon alpha-2
Interferon-alpha - adverse effects
Interferon-alpha - therapeutic use
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Natriuretic Peptide, Brain - drug effects
Recombinant Proteins
Ribavirin - adverse effects
Ribavirin - therapeutic use
title Hemolytic anemia during 24 weeks of ribavirin and interferon-alpha2b combination therapy does not influence the cardiac function of patients with viral hepatitis C
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T14%3A17%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemolytic%20anemia%20during%2024%20weeks%20of%20ribavirin%20and%20interferon-alpha2b%20combination%20therapy%20does%20not%20influence%20the%20cardiac%20function%20of%20patients%20with%20viral%20hepatitis%20C&rft.jtitle=Journal%20of%20clinical%20gastroenterology&rft.au=Sato,%20Shuichi&rft.date=2006-01&rft.volume=40&rft.issue=1&rft.spage=88&rft.pages=88-&rft.issn=0192-0790&rft_id=info:doi/&rft_dat=%3Cpubmed%3E16340643%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/16340643&rfr_iscdi=true